81 related articles for article (PubMed ID: 21837672)
1. Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.
Huqun ; Ishikawa R; Zhang J; Miyazawa H; Goto Y; Shimizu Y; Hagiwara K; Koyama N
Cancer; 2012 Mar; 118(6):1599-606. PubMed ID: 21837672
[TBL] [Abstract][Full Text] [Related]
2. Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker.
Takawa M; Masuda K; Kunizaki M; Daigo Y; Takagi K; Iwai Y; Cho HS; Toyokawa G; Yamane Y; Maejima K; Field HI; Kobayashi T; Akasu T; Sugiyama M; Tsuchiya E; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
Cancer Sci; 2011 Jul; 102(7):1298-305. PubMed ID: 21539681
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.
Ip JC; Pang TC; Glover AR; Soon P; Zhao JT; Clarke S; Robinson BG; Gill AJ; Sidhu SB
Oncologist; 2015 Mar; 20(3):247-56. PubMed ID: 25657202
[TBL] [Abstract][Full Text] [Related]
4. Mutually exclusive expression of EZH2 and H3K27me3 in non-small cell lung carcinoma.
Onishi T; Takashima T; Kurashige M; Ohshima K; Morii E
Pathol Res Pract; 2022 Oct; 238():154071. PubMed ID: 35985089
[TBL] [Abstract][Full Text] [Related]
5. EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis.
Zhang Q; Shi Y; Liu S; Yang W; Chen H; Guo N; Sun W; Zhao Y; Ren Y; Ren Y; Jia L; Yang J; Yun Y; Chen G; Wang L; Wu C
Cell Rep; 2024 Feb; 43(2):113714. PubMed ID: 38306271
[TBL] [Abstract][Full Text] [Related]
6. EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.
DuCote TJ; Song X; Naughton KJ; Chen F; Plaugher DR; Childress AR; Gellert AR; Skaggs EM; Qu X; Liu J; Liu J; Li F; Wong KK; Brainson CF
Cancer Res Commun; 2024 Feb; 4(2):388-403. PubMed ID: 38265267
[TBL] [Abstract][Full Text] [Related]
7. NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer.
Xu X; Wang D; Xu W; Li H; Chen N; Li N; Yao Q; Chen W; Zhong J; Mao W
Commun Biol; 2024 Feb; 7(1):206. PubMed ID: 38378967
[TBL] [Abstract][Full Text] [Related]
8. ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression.
Chen L; Zhang D; Chen Y; Zhu H; Liu Z; Yu Z; Xie J
Oncol Lett; 2024 Mar; 27(3):96. PubMed ID: 38288041
[TBL] [Abstract][Full Text] [Related]
9. The potential of EZH2 expression to facilitate treatment choice in stage II colorectal adenocarcinoma.
Zhu X; He L; Zheng Z; Wang Y; Yang J; Zhang B; Wang C; Li Z
Histol Histopathol; 2024 Mar; ():18732. PubMed ID: 38567631
[TBL] [Abstract][Full Text] [Related]
10. Advancing Nonsmall Cell Lung Cancer Diagnosis Accuracy via Dual Detection Fluorescent Nanoprobes.
Wang Y; Chang Z; Ouyang M; Wang K; Gao X; Tang B
Anal Chem; 2024 Apr; 96(17):6812-6818. PubMed ID: 38634576
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer.
Hashimoto T; Kurokawa Y; Wada N; Takahashi T; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
Oncol Lett; 2020 Jan; 19(1):1066-1073. PubMed ID: 31897220
[TBL] [Abstract][Full Text] [Related]
12. EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells.
Zhang X; Ma X; Wang Q; Kong Z
Transl Oncol; 2022 Feb; 16():101316. PubMed ID: 34952334
[TBL] [Abstract][Full Text] [Related]
13. EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability.
Wang H; Wang L; Zhang S; Liu Q; Gao F
Cancer Cell Int; 2024 May; 24(1):175. PubMed ID: 38764053
[TBL] [Abstract][Full Text] [Related]
14. A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center.
Russell AM; Pack AP; Bailey SC; Weldon CB; Dreyer MS; Kircher SM; Wolf MS
Cancer; 2024 Jun; 130(12):2085-2090. PubMed ID: 38353425
[No Abstract] [Full Text] [Related]
15. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
Mouradov D; Sloggett C; Jorissen RN; Love CG; Li S; Burgess AW; Arango D; Strausberg RL; Buchanan D; Wormald S; O'Connor L; Wilding JL; Bicknell D; Tomlinson IP; Bodmer WF; Mariadason JM; Sieber OM
Cancer Res; 2014 Jun; 74(12):3238-47. PubMed ID: 24755471
[TBL] [Abstract][Full Text] [Related]
16. Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC).
Chandnani N; Choudhari VS; Talukdar R; Rakshit S; Shanmugam G; Guchait S; Gupta I; George M; Sarkar K
Med Oncol; 2023 May; 40(7):185. PubMed ID: 37212947
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
18. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Krill L; Deng W; Eskander R; Mutch D; Zweizig S; Hoang B; Ioffe O; Randall L; Lankes H; Miller DS; Birrer M
Gynecol Oncol; 2020 Feb; 156(2):423-429. PubMed ID: 31843273
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles.
Visser S; Hou J; Bezemer K; de Vogel LL; Hegmans JPJJ; Stricker BH; Philipsen S; Aerts JGJV
BMC Cancer; 2019 May; 19(1):440. PubMed ID: 31088547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
